Skip to search formSkip to main contentSkip to account menu

Azlocillin

Known as: Azlocilline, 4-Thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 3,3-dimethyl-7-oxo-6-(((((2-oxo-1-imidazolidinyl)carbonyl)amino)phenylacetyl)amino)-, (2S-(2alpha,5alpha,6beta(S*)))-, Azlocilina 
A semisynthetic, extended spectrum acylampicillin with antibacterial activity. Azlocillin binds to penicillin-binding proteins (PBPs) located inside… 
National Institutes of Health

Related topics

Related topics

13 relations

Broader (1)

Anti-Bacterial Agents

Narrower (4)

AzlinBay-e 6905Securopenfurazlocillin
Azlocillin sodiumIn Bloodagonistsanalogs & derivatives

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1987
1987
Comparative efficacy of ciprofloxacin, azlocillin, and tobramycin alone and in combination in experimental Pseudomonas sepsis.
Ciprofloxacin, azlocillin, and tobramycin, used alone and in combination, were studied in a model of lethal pseudomonas sepsis in… 
Review
1983
Review
1983
Review of the pharmacokinetics and dose dependency of azlocillin in normal subjects and patients with renal insufficiency.
Cross-over studies on volunteers with several doses of azlocillin ranging from 1.0 to 5.0 g have shown that azlocillin is subject… 
1982
1982
Dose-dependent pharmacokinetics of azlocillin compared to mezlocillin.
The pharmacokinetics of azlocillin at intravenous doses of 1.0, 2.0 and 5.0 g and of 2.0 g mezlocillin were studied in a cross… 
1982
1982
Chemotherapy against Pseudomonas aeruginosa in cystic fibrosis. A study of carbenicillin, azlocillin or piperacillin in combination with tobramycin.
A comparative study was made on tobramycin combined with either carbenicillin (500 mg/kg/day) or one of the new penicillins… 
1981
1981
In vitro inactivation of gentamicin, tobramycin, and netilmicin by carbenicillin, azlocillin, or mezlocillin.
The in vitro inactivation of gentamicin, tobramycin, and netilmicin, when combined with carbenicillin, azlocillin, and… 
1981
1981
Azlocillin with and without an aminoglycoside against respiratory tract infections in children with cystic fibrosis.
Nine patients with cystic fibrosis have been treated with azlocillin alone and later with azlocillin combined with an… 
1981
1981
Azlocillin and gentamicin in respiratory tract infections with Pseudomonas aeruginosa in patients with cystic fibrosis.
Azlocillin, 200 mg/kg bodyweight every 8 h, and gentamicin, 2.5-4 mg/kg bodyweight every 12 h, in combination were given… 
1980
1980
Azlocillin in respiratory tract infections with Pseudomonas aeruginosa in children with cystic fibrosis.
In 5 children with cystic fibrosis, 13 courses of lower respiratory infections due to Pseudomonas aeruginosa were treated with… 
1980
1980
Pharmacokinetics of azlocillin in neonates.
The pharmacokinetics of the acylureido-penicillin, azlocillin, were studied after intravenous or intramuscular injections in 53… 
1979
1979
Pharmacokinetics of azlocillin in children with cystic fibrosis.
6-E1(R)-2-(oxo-imidazolidine-1-carboxamido)-2-phenyl-acetamido]-penicillanic acid sodium salt (azlocillin, Securopen) was given…